Bausch Health Companies Inc. Number of Reportable Segments
Bausch Health Companies Inc. (BHC) reported Number of Reportable Segments of 5 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-07-30
- Bausch Health Companies Inc. number of reportable segments for the quarter ending 2013-03-31 was 2.00 item.
- Bausch Health Companies Inc. number of reportable segments for fiscal 2012 was 4.00 item.
item
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|
| 2013-03-31 | 2.00 item 10-Q · filed 2013-05-03 | ||
| 2012-12-31 | 4.00 item 10-K · filed 2013-02-28 | ||
| 2012-09-30 | 4.00 item 10-Q · filed 2012-11-05 |
segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 5.00 segment 10-Q · filed 2026-07-30 | |||
| 2026-03-31 | 5.00 segment 10-Q · filed 2026-04-30 | |||
| 2025-12-31 | 5.00 segment 10-K · filed 2026-02-19 | |||
| 2017-12-31 | 3.00 segment 10-K · filed 2018-02-28 | |||
| 2017-09-30 | 3.00 segment 10-Q · filed 2017-11-07 | |||
| 2017-06-30 | 3.00 segment 10-Q · filed 2017-08-08 | |||
| 2017-03-31 | 3.00 segment 10-Q · filed 2017-05-09 | |||
| 2016-12-31 | 3.00 segment 10-K · filed 2017-03-01 | |||
| 2016-09-30 | 3.00 segment 10-Q · filed 2016-11-09 | 3.00 segment 10-Q · filed 2016-11-09 | ||
| 2016-06-30 | 2.00 segment 10-K · filed 2019-02-20 | |||
| 2016-03-31 | 2.00 segment 10-Q · filed 2016-06-07 | |||
| 2015-12-31 | 2.00 segment 10-K · filed 2016-04-29 | |||
| 2015-09-30 | 2.00 segment 10-Q · filed 2015-10-26 | |||
| 2015-06-30 | 2.00 segment 10-Q · filed 2015-07-28 | |||
| 2015-03-31 | 2.00 segment 10-Q · filed 2015-04-30 | |||
| 2014-12-31 | 2.00 segment 10-K · filed 2015-02-25 |
segments
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2014-09-30 | 2.00 segments 10-Q · filed 2014-10-24 | |||
| 2014-06-30 | 2.00 segments 10-Q · filed 2014-08-01 | |||
| 2014-03-31 | 2.00 segments 10-Q · filed 2014-05-09 | |||
| 2013-12-31 | 2.00 segments 10-K · filed 2014-02-28 | |||
| 2013-09-30 | 2.00 segments 10-Q · filed 2013-11-01 | |||
| 2013-06-30 | 2.00 segments 10-Q · filed 2013-08-07 | |||
| 2013-03-31 | 2.00 segments 10-K · filed 2014-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |